Increase in transcription of Brf1 and Pol III genes promotes tumor formation (Johnson et al., 2008; Zhong et al., 2011), while high Brf1 expression results in shorter survival period for the patients of hepatocellular carcinoma (Zhong et al., 2016). This evidence concerns the gene BRF1 and neoplasm.